Compensation Plans

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Compensation Plans

15. Compensation Plans

The Company provides stock-based and equity-based compensation in the form of (a) restricted stock awards and restricted stock units to certain employees (the “Restricted Stock”), (b) stock option awards, unrestricted stock awards and stock appreciation rights to employees, directors and consultants under various plans (the “Common Stock Options”), and (c) common stock warrants, referred to as the ABG Warrants and Publisher Partner Warrants (collectively the “Warrants”) as referenced in the below table.

Stock-based compensation and equity-based expense charged to operations or capitalized are summarized as follows:

	Three Months Ended March 31, 2024
	Restricted Stock		Common Stock Options		Warrants		Totals
Cost of revenue	$	35	$	347	$	3	$	385
Selling and marketing		2		107		-		109
General and administrative		190		229		-		419
Total costs charged to operations		227		683		3		913
Capitalized platform development		-		208		-		208
Total stock-based compensation	$	227	$	891	$	3	$	1,121

	Three Months Ended March 31, 2023
	Restricted Stock		Common Stock Options		Warrants		Totals
Cost of revenue	$	794	$	1,189	$	-	$	1,983
Selling and marketing		65		303		-		368
General and administrative		2,352		1,288		246		3,886
Total costs charged to operations		3,211		2,780		246		6,237
Capitalized platform development		-		307		-		307
Total stock-based compensation	$	3,211	$	3,087	$	246	$	6,544

Unrecognized compensation expense and expected weighted-average period to be recognized related to the stock-based compensation awards and equity-based awards as of March 31, 2024 were as follows:

	As of March 31, 2024
	Restricted Stock		Common Stock Options		Warrants		Totals
Unrecognized compensation expense	$	1,052	$	1,939	$	23	$	3,014
Weighted average period expected to be recognized (in years)		1.55		1.39		1.77		1.45

Modification of Warrants – On January 2, 2024, in connection with the default under the Licensing Agreement, the Performance-Based Warrants totaling 599,724 vested as a result of the default pursuant to certain provisions where all of the warrants automatically vest upon certain terminations of the Licensing Agreement by ABG. Of the warrants that vested, 449,793 had an exercise price of $9.24 per share and 149,931 had an exercise price of $18.48 per share.

Modification of Awards – On February 28, 2023, the Company modified certain equity awards as a result of the resignation of a senior executive employee where 38,026 restricted stock units with time-based vesting that were unvested were vested and 21,117 options for shares of the Company’s common stock with time-based vesting that were unvested were vested, each subject to compliance with applicable securities laws and certain other provisions. In connection with the modification of these equity awards, the Company agreed to purchase a options exercisable for 45,632 shares of the Company’s common stock (including previously vested options of shares of the Company’s common stock of 24,515) as of the resignation date of the employee at a price of $10.29 per share, reduced by the exercise price and required tax withholdings, subject to certain conditions. The modification of the equity awards resulted in the unamortized costs being recognized at the modification date. The cash price of $10.29 per option less the strike price of $8.82 per option resulted in incremental cost of $68 being recognized at the modification date. The modification resulted in liability classification of the equity awards, with $68 paid during the three months ended March 31, 2023.